Sherman Jeffrey Scott's Form 4 filing
Neogenomics Inc (NEO) · filed Aug 6, 2025
- Accession no.
- 0001628280-25-038324
- Filed
- Aug 6, 2025
- Trade date
- Aug 6, 2025
- Filing delay
- Same day
- Rule 10b5-1 plan
- Not checked
This filing lists 1 non-derivative transaction and 0 derivative transactions. Open-market purchases total $112.4K. It was filed on the trade date.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Sherman Jeffrey ScottCIK 0001463145 | Officer (Chief Financial Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 6, 2025 | Common Stock | PPurchaseAcquired | +20,000 | $5.62 | +$112,400 | 188,332 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.